Cancer control group (CC) possessed relatively high secretion of IL-6, IFN-γ, MCP-1, IL-10, IL-12p70 and TNF-α from week 1 until week 4 compared with other groups [Figs. 1, 2, 3, 4, 5 and 6]. The gene discussed is CCL2; the disease is cancer.